CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization
Long-term follow-up of the CvLPRIT trial shows that the risk of major adverse cardiovascular events continues to favor STEMI patients with obstructive multivessel disease who underwent complete revascularization compared with patients who had PCI of the culprit lesion only. Complete…